Subscribe To

Price Alert Latest News Economic Calendar News

ZVSA / ZyVersa Therapeutics to Present at BIO CEO & Investor Conference

WESTON, Fla., Jan. 25, 2023 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for the treatment of inflammatory and renal diseases with high unmet medical needs, announced today that Stephen C. Glover, Co-Founder, Chairman, Chief Executive Officer, and President will present in person at the BIO CEO & Investor Conference being held February 6-7, 2023 at the Marriot Marquis in New York City. Read More

Demo Live Account See Partner Details

Content Topics

Zyversa

Therapeutics

Present

Investor

Conference

Stock

ZVSA

Posted: Jan 25 2023, 09:45

Author Name: GlobeNewsWire

ZVSA News

By GlobeNewsWire
April 11, 2023

ZyVersa Therapeutics' CEO, Stephen C. Glover, to Present at Planet MicroCap Showcase

WESTON, Fla., April 11, 2023 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceut

By InvestorPlace
March 23, 2023

Why Is ZyVersa Therapeutics (ZVSA) Stock Up 35% Today?

ZyVersa Therapeutics (NASDAQ: ZVSA ) stock is taking off on Thursday without any recent news from the biopharmaceutical company. Instead, it looks lik

By InvestorPlace
February 2, 2023

Why Is ZyVersa Therapeutics (ZVSA) Stock Up 94% Today?

ZyVersa Therapeutics (NASDAQ: ZVSA ) stock is flying higher on Thursday as investors react to a preliminary prospectus for a stock offering. The stock

By GlobeNewsWire
January 25, 2023

ZyVersa Therapeutics to Present at BIO CEO & Investor Conference

WESTON, Fla., Jan. 25, 2023 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceuti

By GlobeNewsWire
January 11, 2023

ZyVersa Therapeutics' CEO, Stephen C. Glover, to Present at the Virtual Investor 2023 Companies to Watch Event

Live video webcast on Wednesday, January 18th at 2:00 PM ET

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.